Citation Impact
Citing Papers
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
2010
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
2008
Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma
2006
Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer
2005
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
2007 Standout
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
2005
Signaling pathways in retinoid chemoprevention and treatment of cancer
2004
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
The DNA-damage response in human biology and disease
2009 StandoutNature
Aberrant Methylation of Hypermethylated-in-Cancer-1 and Exocyclic DNA Adducts in Tobacco Smokers
2013
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
MYC on the Path to Cancer
2012 Standout
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Oxy radicals, lipid peroxidation and DNA damage
2002
Lipid peroxidation—DNA damage by malondialdehyde
1999
Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: A review of published adduct types and levels in humans
2007
Advances in metal-induced oxidative stress and human disease
2011 Standout
Incidence and Impact of Documented Eradication of Breast Cancer Axillary Lymph Node Metastases Before Surgery in Patients Treated With Neoadjuvant Chemotherapy
1999
Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma
2000
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
2005 StandoutNature
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Bcr–Abl variants: biological and clinical aspects
2002
Significance of histopatholoaical evaluation in primary therapy for breast cancer-recent trends in primary modality with pathological complete response(pCR) as endpoint
2004
Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein
2010 StandoutNobel
Sialyltransferases in cancer
2001
Loss of Retinoic Acid Receptor-β Expression Is an Early Event during Esophageal Carcinogenesis
1999
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity
2005
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Apoptosis in Young Rats with Adriamycin-Induced Cardiomyopathy—Comparison with Pirarubicin, a New Anthracycline Derivative
2002
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response
2004
Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells
1998
Oxyradicals and DNA damage
2000
Cloning and expression of a human gene encoding an N-acetylgalactosamine- 2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens
1999
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Cdc7-Dbf4 and the Human S Checkpoint Response to UVC
2007 StandoutNobel
c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
2002
Generation of a functional mammary gland from a single stem cell
2006 StandoutNature
Differential expression of retinoic acid receptor beta (RARβ) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues
2004
Golgi Localization of Carbohydrate Sulfotransferases Is a Determinant of L-selectin Ligand Biosynthesis
2003 StandoutNobel
Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo-adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process? Experience in 56 Patients Treated in a Single Institution
2010
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
2003 Standout
American Joint Committee on Cancer Tumor–Node–Metastasis Stage After Neoadjuvant Chemotherapy and Breast Cancer Outcome
2005
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology
2004
Mucins in cancer: protection and control of the cell surface
2003
Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer
2005
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Retinoids: present role and future potential
1999
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival
2003
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Incidence and Prognostic Significance of Complete Axillary Downstaging After Primary Chemotherapy in Breast Cancer Patients With T1 to T3 Tumors and Cytologically Proven Axillary Metastatic Lymph Nodes
2002
Duplex DNA catalyzes the chemical rearrangement of a malondialdehyde deoxyguanosine adduct
1999
Hierarchical Assembly of Model Cell Surfaces: Synthesis of Mucin Mimetic Polymers and Their Display on Supported Bilayers
2007 StandoutNobel
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Retinoic acid and interferon combination studies in human cancer
1993
In Vivo Imaging of Membrane-Associated Glycans in Developing Zebrafish
2008 StandoutScienceNobel
Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome
2007
The Use of Alternate, Non–Cross-Resistant Adjuvant Chemotherapy on the Basis of Pathologic Response to a Neoadjuvant Doxorubicin-Based Regimen in Women With Operable Breast Cancer: Long-Term Results From a Prospective Randomized Trial
2004
Nomograms to Predict Pathologic Complete Response and Metastasis-Free Survival After Preoperative Chemotherapy for Breast Cancer
2005
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
2003
Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice
2004
Quality Control by DNA Repair
1999 StandoutScienceNobel
Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat
1999
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
2006
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer.
2003
Functional Role of Type I and Type II Interferons in Antiviral Defense
1994 StandoutScience
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer
2005
National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
2001
Unique anti-activator protein-1 activity of retinoic acid receptor beta.
2000
Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy
2005
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
2007 Standout
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and Docetaxel Every 14 Days As Preoperative Treatment in Operable Breast Cancer: The GEPARDUO Study of the German Breast Group
2005
Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis
2016 StandoutNobel
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
2006
Cytokine therapeutics: lessons from interferonalpha.
1994
Interfacing Carbon Nanotubes with Living Cells
2006 StandoutNobel
Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence
2008
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
DNA damage caused by lipid peroxidation products.
2003
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
2002
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
Noncovalent Cell Surface Engineering: Incorporation of Bioactive Synthetic Glycopolymers into Cellular Membranes
2008 StandoutNobel
Removal of oxygen free-radical-induced 5′,8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells
2000 StandoutNobel
Expression of sialyl-Tn epitopes on β1 integrin alters epithelial cell phenotype, proliferation and haptotaxis
2004
Works of Kapil Dhingra being referenced
Expression of leukemia inhibitory factor and its receptor in breast cancer: A potential autocrine and paracrine growth regulatory mechanism
1998
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer
1998
The prognostic significance of sialyl-tn Antigen in women treated with breast carcinoma treated with adjuvant chemotherapy
1997
Effect of chromosome size on aberration levels caused by gamma radiation as detected by fluorescence in situ hybridization
1994
Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer
1998
Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma
1993
Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia
1991
Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia
1991
Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
1999
Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy.
1994
Phase I Study of a Third-Generation Selective Estrogen Receptor Modulator, LY353381.HCl, in Metastatic Breast Cancer
2001
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
1998
Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.
1992
Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
1996
The effects of anaemia on heart, placenta and body weight, and blood pressure in fetal and neonatal rats.
1995
Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
1995
Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
1996
Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis.
1997